Rocio Diaz-Granda

Oviedo, AS, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications

Retraction notice to "Targeting oncogenic functions of miR-301a in head and neck squamous cell carcinoma by PI3K/PTEN and MEK/ERK pathways" [Biomedicine & Pharmacotherapy 161 (2023) 114512].

Retraction notice to "Targeting oncogenic functions of miR-301a in head and neck squamous cell carcinoma by PI3K/PTEN and MEK/ERK pathways" [Biomedicine & Pharmacotherapy 161 (2023) 114512].

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: June 17, 2026

The double-edged role of interferon gamma in cancer immunity.

The double-edged role of interferon gamma in cancer immunity.

Journal: International review of cell and molecular biology
Published: May 20, 2026

Cytokine network in immunosuppression and tumor development in glioblastoma.

Cytokine network in immunosuppression and tumor development in glioblastoma.

Journal: International review of cell and molecular biology
Published: May 20, 2026

Phosphoflow: Evaluation of Protein Phosphorylation Status by Cytofluorimetric Assay.

Phosphoflow: Evaluation of Protein Phosphorylation Status by Cytofluorimetric Assay.

Journal: Methods in molecular biology (Clifton, N.J.)
Published: May 22, 2025

A Colony Formation-Based Assay to Evaluate Natural Killer Cell Antitumor Responses In Vitro.

A Colony Formation-Based Assay to Evaluate Natural Killer Cell Antitumor Responses In Vitro.

Journal: Methods in molecular biology (Clifton, N.J.)
Published: May 22, 2025

The immune checkpoint LILRB4 promotes immune evasion and is correlated with disease progression and secondary malignancies in chronic lymphocytic leukemia.

The immune checkpoint LILRB4 promotes immune evasion and is correlated with disease progression and secondary malignancies in chronic lymphocytic leukemia.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 27, 2025

Correction: Deciphering LAG-3: unveiling molecular mechanisms and clinical advancements.

Correction: Deciphering LAG-3: unveiling molecular mechanisms and clinical advancements.

Journal: Biomarker research
Published: November 12, 2024

Deciphering LAG-3: unveiling molecular mechanisms and clinical advancements.

Deciphering LAG-3: unveiling molecular mechanisms and clinical advancements.

Journal: Biomarker research
Published: September 03, 2024

CDK7-targeted therapy effectively disrupts cell cycle progression and oncogenic signaling in head and neck cancer.

CDK7-targeted therapy effectively disrupts cell cycle progression and oncogenic signaling in head and neck cancer.

Journal: Signal transduction and targeted therapy
Published: September 02, 2024

Combined PIK3CA and SOX2 Gene Amplification Predicts Laryngeal Cancer Risk beyond Histopathological Grading.

Combined PIK3CA and SOX2 Gene Amplification Predicts Laryngeal Cancer Risk beyond Histopathological Grading.

Journal: International journal of molecular sciences
Published: December 31, 2023

Beyond the anti-PD-1/PD-L1 era: promising role of the BTLA/HVEM axis as a future target for cancer immunotherapy.

Beyond the anti-PD-1/PD-L1 era: promising role of the BTLA/HVEM axis as a future target for cancer immunotherapy.

Journal: Molecular cancer
Published: June 07, 2023

Targeting oncogenic functions of miR-301a in head and neck squamous cell carcinoma by PI3K/PTEN and MEK/ERK pathways.

Targeting oncogenic functions of miR-301a in head and neck squamous cell carcinoma by PI3K/PTEN and MEK/ERK pathways.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: January 27, 2023
Showing 1-12 of 28

Last Updated: 09/26/2026